Moderna Targets 2021 Back-To-School Season For Pediatric Data On COVID-19 Vaccine

Sponsors are moving to younger populations as the adult clinical trials near enrollment goals; Moderna’s CEO says data in children younger than 12 will be slow to emerge.

Child with face mask getting vaccinated
The FDA said the expanded access pathway will not be used to make a vaccine available for children unless safety and immunogenicity data in that group is available. • Source: Shutterstock

The summer of 2021 may be the period the world moves from discussing coronavirus vaccines in adults to inoculating children.

Children were purposely not included in the initial clinical trials of the various vaccine candidates

More from Vaccines

More from Pink Sheet